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BY-NC-ND license (http://creativecomAbstract Background: With its epicenter in Wuhan, China, the COVID-19 outbreak was
declared a pandemic by the World Health Organization (WHO). While many countries have im-
plemented flight restrictions to China, an increasing number of cases with or without travel
background to China are confirmed daily. These developments support concerns on possible
unidentified and unreported international COVID-19 cases, which could lead to new local dis-
ease epicenters.
Methods: We have analyzed all available data on the development of international COVID-19
cases from January 20th, 2020 until February 18th, 2020. COVID-19 cases with and without
travel history to China were divided into cohorts according to the Healthcare Access and Qual-
ity Index (HAQ-Index) of each country. Chi-square and Post-hoc testing were performed.
Results: While COVID-19 cases with travel history to China seem to peak for each HAQ-cohort,
the number of non-travel related COVID-19 cases seem to continuously increase in the HAQ-
cohort of countries with higher medical standards. Further analyses demonstrate a signifi-
cantly lower proportion of reported COVID-19 cases without travel history to China in countries
with lower HAQ (HAQ I vs. HAQ II, posthoc p < 0.01).
Conclusions: Our data indicate that countries with lower HAQ-index may either underreport
COVID-19 cases or are unable to adequately detect them. Although our data may be incom-
plete and must be interpreted with caution, inconsistencies in reporting COVID-19 cases is a
serious problem which might sabotage efforts to contain the virus.of Surgery, University of California Irvine (UCI), 333 City Boulevard West, Suite 850, Orange, CA,
ail.com (T. Khosrawipour).
l., Internationally lost COVID-19 cases, Journal of Microbiology, Immunology and Infection, https://
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nc-nd/4.0/).Introduction
With continuously rising numbers of confirmed cases, the
current outbreak of coronavirus (COVID-19) in Wuhan and
the entire Hubei province has developed into a global
health threat.
Current knowledge on the biology and transmission of
this virus is limited,1,2 and final mortality rates attributed
to COVID-19 are subject to rough estimation. Consequently,
international flight traffic has been reduced, and the Hubei
province was placed under lockdown approximately 3
weeks after the start of the COVID-19 outbreak. According
to some sources, the first estimated date of reported
COVID-19 cases was in December 2019.3 Due to the
continuous rise in confirmed international COVID-19 cases,
it remains uncertain whether a further uncontrolled virus
outbreak can be prevented. One probable scenario suggests
that COVID-19 cases outside of China might spread and
remain undetected for a relevant time period, resulting in
delayed countermeasures in many countries. In fact, new
current disease epicenters have formed in Italy, Japan,
South Korea and Iran.
However, these considerations are hypothetical since
we have too limited information on transmission patterns
of affected COVID-19 patients outside of China. Moreover,
making any assumptions is difficult with only limited
available data on international COVID-19 spread. The aim
of this study is to assess the extent of undetected, missing,
undiagnosed, or unreported COVID-19 cases on an inter-
national level. While some industrialized countries with
high health standards report massively increased case
numbers, reported cases in countries with lower health
standards, except for Iran, remain low. By means of this
study, we aim to evaluate if the analyzed data points to
possible lost COVID-19 cases outside China, particularly in
countries with lower Healthcare Access and Quality Indices
(HAQ Index).
If there are indeed unreported international cases, we
assume these to be in countries with lower medical stan-
dards as measured by the Healthcare Access and Quality
Index (HAQ Index). More specifically, we suspect countries
without regular air traffic to China be more vulnerable, as
they may feel an increased sense of safety and thus not pay
enough attention to safety protocols and detection mea-
sures. Hence, by means of this study, we will analyze
whether there is any indication of underreported COVID-19
cases in countries with a lower HAQ vs. higher HAQ-Index
countries. We will compare the amount of COVID-19 cases
in both groups by distinguishing the relation of non-travel
associated COVID-19 cases vs. those with travel history to
China. If our assumptions are incorrect, there should be no
significant differences in the relation between these groups
and these countries.l., Internationally lost COVID-19 cMaterial and methods
Data sources
Healthcare Access and Quality Index (HAQ index)
The HAQ Index of 25 countries with confirmed COVID-19
cases reported by the WHO was sourced from a previously
published study by the GBD 2016 Healthcare Access and
Quality Collaborators.4
Confirmed COVID-19 cases
The total number of confirmed international COVID-19
cases with or without travel history to China were
sourced from publicly available COVID-19 situation reports.
This current study analyzed data from January 20th, 2020
until February 18th, 2020. In each situation report, cases
with the description “transmission site under investigation”
were excluded from the analysis as the original site of viral
transmission was unknown.
Development of international COVID-19 cases
To identify the peak of new cases, we quantified the
number of new confirmed international COVID-19 cases per
day with and without travel history to China from January
20th, 2020 to February 18th, 2020 (Fig. 1).
Correlation of Healthcare Access and quality (HAQ) and
reported COVID-19 cases
We determined the correlation between the number of
COVID-19 cases outside of China and the HAQ index of each
country with confirmed COVID-19 cases using a least square
regression line. We used three correlation studies: 1) total
reported international cases vs. HAQ Index 2) cases with
travel history and 3) cases without travel history to China.
HAQ index, chi-square and post-hoc test
Applying the decile set constructed by the GBD 2016
Healthcare Access and Quality Collaborators, we catego-
rized countries with confirmed COVID-19 cases into three
distinct groups based on their HAQ index (Group I: 82.2 -
>91.3, Group 2: 63.2e82.2, Group 3: 35.9e63.2) We
analyzed the relation between HAQ index and travel history
of confirmed COVID-19 cases outside of China. For this
purpose, a chi-square test with post-hoc analysis was per-
formed on the cohorts.
Development of international case numbers according to
HAQ index
For further graphical analyses, we classified confirmed
COVID-19 cases with or without travel history to China into
two groups according to their HAQ index (Group A:
68.9 / 91.3, group B: 35.9 / 68.9) and investigated the
association between these. In group A, we quantified theases, Journal of Microbiology, Immunology and Infection, https://
Figure 1. Development of international COVID-19 cases from January 20th, 2020 to February 18th, 2020 according to travel
history to China. Beginning of lockdown in Wuhan (Hubei province) and major international flight restrictions.
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day with and without travel history to China from January
20th, 2020 to February 18th, 2020 (Fig. 2A). Then the same
was applied to Group B (Fig. 2B). Lastly, we ran a chi-square
test with post-hoc analysis on the two cohorts.
Statistical analysis
Correlation analysis was performed using linear regression.
A chi-square test with post-hoc analysis was used to
determine the relationship between the HAQ index and
travel history of confirmed international COVID-19 cases. P-
values <0.05 were considered statistically significant. AllFigure 2. Development of international COVID-19 cases from Janu
(B) according to travel history to China. Beginning of lockdown
restrictions.
Please cite this article as: Lau H et al., Internationally lost COVID-19 c
doi.org/10.1016/j.jmii.2020.03.013statistical analyses were performed on IBM SPSS Statistics
(SPSS Inc., version 25).
Results
Development of international COVID-19 cases
Analysis of confirmed international COVID-19 cases show a
shift from cases with travel history to China to cases with
either confirmed or possible transmission outside of China.
Cases with travel history to China peaked on February 1st,ary 20th, 2020 to February 18th, 2020 for HAQ-A (A) and HAQ-B
in Wuhan (Hubei province) and major international flight
ases, Journal of Microbiology, Immunology and Infection, https://
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+ MODEL2020 and seem to reach nearly zero after February 14th,
2020. Cases without travel history to China show no indi-
cation of peaking (see Fig. 1).
Correlation of Healthcare Access and Quality (HAQ)
with reported COVID-19 cases
The correlation analysis of the HAQ index of 25 countries
and their respective total number of confirmed COVID-19
cases showed no significant correlation (r Z 0.28,
r2 Z 0.077, p > 0.05), Moreover, HAQ index was not
correlated to number of confirmed international COVID-19
cases with travel history to China (r Z 0.2, r2 Z 0.04,
p > 0.05). Similarly, HAQ index had no significant correla-
tion to the number of international COVID-19 cases without
travel history to China (r Z 0.3, r2 Z 0.08, p > 0.05).
Application of HAQ index, chi-square and post-hoc
test
An independent chi-square test indicated a significant
relationship between HAQ index of 25 countries divided
into 3 groups and travel history to China of confirmed
COVID-19 cases (Chi-square Z 27.27, p < 0.01). Post-hoc
analysis further showed that countries in group HAQ Index I
were linked to significantly more COVID-19 cases without
travel history to China (p < 0.01). On the other hand,
countries in group HAQ Index II were more likely to have
more cases with travel history to China (p < 0.01).
Development of international case numbers
according to HAQ index
For Group A, the development of new confirmed interna-
tional COVID-19 cases per day with and without travel his-
tory to China from January 20th, 2020 to February 18th,
2020 showed two main tendencies (Fig. 2A). Cases with
travel history to China seem to peak while cases without
travel history show a massive rise and surpass cases with
travel history by February 18th, 2020 (Fig. 2A). In group B,
the development of new confirmed international COVID-19
cases per day with and without travel history to China show
a different pattern (observation period is January 20th,
2020 to February 18th, 2020, see Fig. 2A). Both cases with
and without travel history to China seem to peak (Fig. 2B).Figure 3. Total number of COVID-19 cases (for each HAQ A and B
and related statistical data.
Please cite this article as: Lau H et al., Internationally lost COVID-19 c
doi.org/10.1016/j.jmii.2020.03.013Chi-square test reveals a significant difference between
both HAQ- A and HAQ-B cases related to their background
(Chi-square 8.9, p < 0.01) (Fig. 3).
Discussion
While it is very difficult to assess if and how many uniden-
tified COVID-19 cases exist outside of China, our data
indicate that unreported or undetected cases are likely,
especially in countries with low HAQ index. Interestingly,
most unidentified cases in these countries are not associ-
ated with travel history to China. This study is the first to
investigate the role of unidentified COVID-19 cases with
respect to the virus’ spread pattern. Despite limited data
and constantly changing case numbers available at the time
of analysis, our findings indicate that despite enormous
efforts launched by China to contain COVID-19 spread,
there is a significant danger of a continuous undetected
spread of COVID-19 cases. It is possible that, at later stages,
multiple COVID-19 epicenters appear in developing coun-
tries as seen by the latest explosion of case numbers in Iran.
This development in countries without sustainable medical
surveillance can give further rise to both local and global
virus outbreaks. In this case, despite continuous restrictions
in air traffic, shipping, or other means of transportation,
COVID-19 might further establish itself as a pandemic,
especially since this virus shows exceptionally high trans-
mission rates and structural stability on surfaces.5,6 With
only limited data available, results must be evaluated with
caution. We also want to emphasize that results cannot be
generalized. There will be exceptions to this depending on
the local situation. For example, Taiwan has many more
imported than locally transmitted COVID-19 cases but has
also performed extensive laboratory studies among both
groups of patients with and without travel background to
China. Other reasons for potential increasing COVID-19 case
numbers might be because infected travelers from China
may have traveled to developed countries earlier as well as
more frequently than to developing countries. This could
have facilitated local spread much earlier than was
detected, considering the incubation time of 7e14 days.
Furthermore, developed countries more often hold inter-
national conferences and meetings with Chinese partici-
pants, another aspect which could have facilitated the
spread of COVID-19. In these cases, conference participants
would not be classified as individuals with travelgroup). Case numbers according to the travel history with China
ases, Journal of Microbiology, Immunology and Infection, https://
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concerns of a continuous global COVID-19 spread.Conclusion
Our data support the scenario of a continuous spread of
COVID-19 cases. Especially in countries with low HAQ
indices, undetected COVID-19 cases which are not attrib-
uted to travel to China may give rise to new virus epicenters
across the globe. While enormous measures have been
taken to prevent virus spread, including quarantine, lock-
downs and travel restrictions, more efforts and resources
should be dedicated toward developing a new vaccine as
soon as possible.Availability of data and materials
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